191 related articles for article (PubMed ID: 37770957)
1. Cystine/glutamate antiporter xCT deficiency reduces metastasis without impairing immune system function in breast cancer mouse models.
Ruiu R; Cossu C; Iacoviello A; Conti L; Bolli E; Ponzone L; Magri J; Rumandla A; Calautti E; Cavallo F
J Exp Clin Cancer Res; 2023 Sep; 42(1):254. PubMed ID: 37770957
[TBL] [Abstract][Full Text] [Related]
2. Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer.
Conti L; Bolli E; Di Lorenzo A; Franceschi V; Macchi F; Riccardo F; Ruiu R; Russo L; Quaglino E; Donofrio G; Cavallo F
Cancer Immunol Res; 2020 Aug; 8(8):1039-1053. PubMed ID: 32532810
[TBL] [Abstract][Full Text] [Related]
3. Cystine-glutamate antiporter xCT deficiency suppresses tumor growth while preserving antitumor immunity.
Arensman MD; Yang XS; Leahy DM; Toral-Barza L; Mileski M; Rosfjord EC; Wang F; Deng S; Myers JS; Abraham RT; Eng CH
Proc Natl Acad Sci U S A; 2019 May; 116(19):9533-9542. PubMed ID: 31019077
[TBL] [Abstract][Full Text] [Related]
4. The glutamate/cystine xCT antiporter antagonizes glutamine metabolism and reduces nutrient flexibility.
Shin CS; Mishra P; Watrous JD; Carelli V; D'Aurelio M; Jain M; Chan DC
Nat Commun; 2017 Apr; 8():15074. PubMed ID: 28429737
[TBL] [Abstract][Full Text] [Related]
5. Immunotargeting of Antigen xCT Attenuates Stem-like Cell Behavior and Metastatic Progression in Breast Cancer.
Lanzardo S; Conti L; Rooke R; Ruiu R; Accart N; Bolli E; Arigoni M; Macagno M; Barrera G; Pizzimenti S; Aurisicchio L; Calogero RA; Cavallo F
Cancer Res; 2016 Jan; 76(1):62-72. PubMed ID: 26567138
[TBL] [Abstract][Full Text] [Related]
6. xCT knockdown in human breast cancer cells delays onset of cancer-induced bone pain.
Ungard RG; Linher-Melville K; Nashed MG; Sharma M; Wen J; Singh G
Mol Pain; 2019; 15():1744806918822185. PubMed ID: 30799686
[TBL] [Abstract][Full Text] [Related]
7. Identification, Expression, and Roles of the Cystine/Glutamate Antiporter in Ocular Tissues.
Martis RM; Knight LJ; Donaldson PJ; Lim JC
Oxid Med Cell Longev; 2020; 2020():4594606. PubMed ID: 32655769
[TBL] [Abstract][Full Text] [Related]
8. Cystine/glutamate antiporter xCT (SLC7A11) facilitates oncogenic RAS transformation by preserving intracellular redox balance.
Lim JKM; Delaidelli A; Minaker SW; Zhang HF; Colovic M; Yang H; Negri GL; von Karstedt S; Lockwood WW; Schaffer P; Leprivier G; Sorensen PH
Proc Natl Acad Sci U S A; 2019 May; 116(19):9433-9442. PubMed ID: 31000598
[TBL] [Abstract][Full Text] [Related]
9. Glial Glutamate Transporter-Mediated Plasticity: System x
Dahlmanns M; Dahlmanns JK; Savaskan N; Steiner HH; Yakubov E
Front Biosci (Landmark Ed); 2023 Mar; 28(3):57. PubMed ID: 37005761
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic PI3K promotes methionine dependency in breast cancer cells through the cystine-glutamate antiporter xCT.
Lien EC; Ghisolfi L; Geck RC; Asara JM; Toker A
Sci Signal; 2017 Dec; 10(510):. PubMed ID: 29259101
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of cystine/glutamate antiporter in multiple sclerosis.
Pampliega O; Domercq M; Soria FN; Villoslada P; Rodríguez-Antigüedad A; Matute C
J Neuroinflammation; 2011 Jun; 8():63. PubMed ID: 21639880
[TBL] [Abstract][Full Text] [Related]
12. Cystine-glutamate antiporter xCT as a therapeutic target for cancer.
Liu L; Liu R; Liu Y; Li G; Chen Q; Liu X; Ma S
Cell Biochem Funct; 2021 Mar; 39(2):174-179. PubMed ID: 32749001
[TBL] [Abstract][Full Text] [Related]
13. Expression of xCT and activity of system xc(-) are regulated by NRF2 in human breast cancer cells in response to oxidative stress.
Habib E; Linher-Melville K; Lin HX; Singh G
Redox Biol; 2015 Aug; 5():33-42. PubMed ID: 25827424
[TBL] [Abstract][Full Text] [Related]
14. Changes in glutamate and glutamine distributions in the retinas of cystine/glutamate antiporter knockout mice.
Knight LJ; Martis RM; Donaldson PJ; Acosta ML; Lim JC
Mol Vis; 2023; 29():274-288. PubMed ID: 38222448
[TBL] [Abstract][Full Text] [Related]
15. Cystine/glutamate exchange modulates glutathione supply for neuroprotection from oxidative stress and cell proliferation.
Shih AY; Erb H; Sun X; Toda S; Kalivas PW; Murphy TH
J Neurosci; 2006 Oct; 26(41):10514-23. PubMed ID: 17035536
[TBL] [Abstract][Full Text] [Related]
16. Genetic Ablation of the Cystine Transporter xCT in PDAC Cells Inhibits mTORC1, Growth, Survival, and Tumor Formation via Nutrient and Oxidative Stresses.
Daher B; Parks SK; Durivault J; Cormerais Y; Baidarjad H; Tambutte E; Pouysségur J; Vučetić M
Cancer Res; 2019 Aug; 79(15):3877-3890. PubMed ID: 31175120
[TBL] [Abstract][Full Text] [Related]
17. Loss of the cystine/glutamate antiporter in melanoma abrogates tumor metastasis and markedly increases survival rates of mice.
Sato M; Onuma K; Domon M; Hasegawa S; Suzuki A; Kusumi R; Hino R; Kakihara N; Kanda Y; Osaki M; Hamada J; Bannai S; Feederle R; Buday K; Angeli JPF; Proneth B; Conrad M; Okada F; Sato H
Int J Cancer; 2020 Dec; 147(11):3224-3235. PubMed ID: 32818320
[TBL] [Abstract][Full Text] [Related]
18. Astrocytes release glutamate via cystine/glutamate antiporter upregulated in response to increased oxidative stress related to sporadic amyotrophic lateral sclerosis.
Kazama M; Kato Y; Kakita A; Noguchi N; Urano Y; Masui K; Niida-Kawaguchi M; Yamamoto T; Watabe K; Kitagawa K; Shibata N
Neuropathology; 2020 Dec; 40(6):587-598. PubMed ID: 33305472
[TBL] [Abstract][Full Text] [Related]
19. Cystine-glutamate antiporter deletion accelerates motor recovery and improves histological outcomes following spinal cord injury in mice.
Sprimont L; Janssen P; De Swert K; Van Bulck M; Rooman I; Gilloteaux J; Massie A; Nicaise C
Sci Rep; 2021 Jun; 11(1):12227. PubMed ID: 34108554
[TBL] [Abstract][Full Text] [Related]
20. Fighting breast cancer stem cells through the immune-targeting of the xCT cystine-glutamate antiporter.
Ruiu R; Rolih V; Bolli E; Barutello G; Riccardo F; Quaglino E; Merighi IF; Pericle F; Donofrio G; Cavallo F; Conti L
Cancer Immunol Immunother; 2019 Jan; 68(1):131-141. PubMed ID: 29947961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]